Progyny, Inc. (PGNY)
Market Cap | 2.70B |
Revenue (ttm) | 1.11B |
Net Income (ttm) | 61.26M |
Shares Out | 95.22M |
EPS (ttm) | 0.62 |
PE Ratio | 45.69 |
Forward PE | 35.61 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,042,173 |
Open | 28.53 |
Previous Close | 28.38 |
Day's Range | 28.01 - 28.53 |
52-Week Range | 23.90 - 44.95 |
Beta | 1.46 |
Analysts | Strong Buy |
Price Target | 44.83 (+58.24%) |
Earnings Date | Aug 1, 2024 |
About PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various servic... [Read more]
Financial Performance
In 2023, Progyny's revenue was $1.09 billion, an increase of 38.34% compared to the previous year's $786.91 million. Earnings were $62.04 million, an increase of 104.35%.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for PGNY stock is "Strong Buy." The 12-month stock price forecast is $44.83, which is an increase of 58.24% from the latest price.
News
Progyny, Inc. to Host 2024 Inaugural Investor Day
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that it will host its inaug...
Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced an expansion of its global ...
Fertility Pioneer and Kindbody Founder Gina Bartasi Returns as CEO to Lead Company's Next Phase of Growth
Kindbody is the Largest Women-founded, Women-led Fertility Company Serving Employers and Families through its National Clinic Network and Proprietary Technology Platform NEW YORK, June 11, 2024 /PRNew...
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny'...
Progyny's board approves another $100 million stock buyback
The board of Progyny PGNY, -2.62% has approved a $100 million share-repurchase authorization, its second this year.
Progyny, Inc. Announces Additional Share Repurchase Program
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, announced today that its Board of Directors ...
Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Progyny's executives wi...
Progyny's stock plunges as demand for IVF treatments drops after Alabama ruling
Shares of Progyny Inc. were headed for a record selloff Friday after the fertility-services company said the Supreme Court of Alabama's February ruling regarding in vitro fertilization seemed to scare...
Progyny, Inc. Announces First Quarter 2024 Results
Early Sales Activity and New Partnerships Provide Strong Start to Selling Season, Affirming Continued Demand for Fertility and Family Building Solutions Early Sales Activity and New Partnerships Provi...
Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the ...
Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care
The organizations will host an event with Canada's leading providers, employers, and fertility advocates to show support for the millions in need of family building care The organizations will host an...
Jim Cramer lays out his top small-cap healthcare picks
'Mad Money' host Jim Cramer shares his small-cap healthcare stock picks.
Jim Cramer recommends five small-cap health-care stocks
CNBC's Jim Cramer said he thinks it could be a good year for small cap stocks and shared his top picks.
Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast
The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges The ...
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny...
This overlooked corner of women's health could be a $350 billion market opportunity
Menopause is among the female health conditions with the highest unmet need and has 'enormous potential for innovative treatments,' according to McKinsey.
Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny...
Progyny, Inc. Announces Share Repurchase Program
NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, announced today that its Board of Directors...
Progyny Stock Is Falling After Earnings. What the IVF Ruling Means for It.
Shares of fertility-solutions firm Progyny are in the red on disappointing guidance. The company says the Alabama court ruling on in vitro fertilization won't affect it.
Progyny, Inc. Announces Fourth Quarter 2023 Results
Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion ...
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2023 Results Report
NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the q...
Vistia Health selects Progyny as its preferred fertility and family building benefits provider
Vistia Health brings Progyny's comprehensive suite of fertility and family building services to its clients PHILADELPHIA , Jan. 17, 2024 /PRNewswire/ -- Vistia Health, a healthcare navigator supportin...
Progyny Expands its Leadership Team
Katie Higgins has been named Chief Commercial Officer and Steven Leist has been named Chief Technology Officer Katie Higgins has been named Chief Commercial Officer and Steven Leist has been named Chi...
Progyny, Inc. to Present at 42nd Annual J.P. Morgan Healthcare Conference
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny's Chie...
Progyny, Inc. to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that P...